Home Search
chronic disorder - search results
If you're not happy with the results, please do another search
Did you know drug combination could treat advanced kidney cancer?
According to researchers from Dana-Farber Cancer Institute, USA, a drug combination could potentially become the first-line treatment for patients with advanced kidney cancer.
Patients who...
Which strategies are most likely to slow down Parkinson’s disease?
Experts explore which of the existing strategies to slow down or stop the processes of Parkinson’s disease are most likely to be successful over...
KannaSwiss: Europe’s leader in CBD research and production
In the emerging cannabis space, KannaSwiss is striving to push the boundaries of CBD research, quality and delivery.
The CBD industry has enjoyed a rapid...
Presenting Lymphit: The tech designed to benefit cancer survivors
Dicronis introduces Lymphit – a cutting-edge technology that will disrupt traditional lymphoedema diagnosis methods for the benefit of cancer survivors.
Patrizia Marschalkova, CEO of Dicronis...
Health Europa Quarterly Issue 08: discover the evolving world of healthcare
Editor Kathryn Washburn introduces the eighth edition of Health Europa Quarterly, talking rare, infectious and chronic diseases the hot topic of medical cannabis.
Medical cannabis...
How to deal with the medical cannabis dilemma
Dr Franjo Grotenhermen, the executive director of the International Association for Cannabinoid Medicines, reflects on the legal challenges around medical cannabis.
There is a general...
The ABCs of colorectal cancer
In 2008 roughly 450,000 new cases of colorectal cancer were diagnosed in Europe – but with the ABC-Cancer project, a state-of-the-art screening tool may...
A spotlight on the lymphatic system
Health Europa takes a closer look at illnesses related to the lymphatic system and the role of the European Society of Lymphology.
The lymphatic system...
Symptoms of memory loss could be symptoms of impaired hearing
Older adults concerned about displaying early symptoms of memory loss should also consider that they may have impaired hearing.
Published in the Canadian Journal on...
IBM fingernail sensor – understanding Parkinson’s with AI
The IBM fingernail sensor prototype has the aim of helping clinicians to continuously track, monitor and more accurately diagnose Parkinson’s disease with AI.
The Michael...
Becoming reality – mucopolysaccharide storage diseases and adulthood
Susanne Gerit Kircher, of the Medical University of Vienna, explains why more resources and effort must be put into understanding mucopolysaccharide storage diseases in...
A call to action for idiopathic pulmonary fibrosis
The EU-IPFF sets out a series of recommendations to improve the quality of life and treatment outcomes of people living with idiopathic pulmonary fibrosis...
Food fraud: are obesogens preventing weight loss?
Although excessive consumption of unhealthy food is the common cause of obesity, scientists are exploring the role chemicals play in obesity, specifically obesogens.
More than...
Tinnitus hearing loss may be avoided amongst a younger population
Experts highlight how Tinnitus hearing loss amongst a younger population could be avoided with a simple check-up.
There are more than six million people in...
Gene therapy process reversing sickle cell anaemia symptoms
After over a decade of preclinical research and development, a new gene therapy process is reversing sickle cell anaemia symptoms in patients.
The gene therapy...
Aerobic exercise may improve kidney function in obesity
Researchers find that aerobic exercise may reduce the risk of diabetes related kidney disease and may even improve kidney function in obesity.
Kidney, renal, disease...
Spotlight: the European Public Health Association
The European Public Health Association is committed to delivering a healthier future for the people of Europe. Read more as Health Europa explores.
The European...
Reference networks and research for rare diseases
Health Europa looks at the diagnosis and treatment of rare diseases and related research efforts. Focusing on the European Reference Networks and the New...
New targeted methotrexate underway for rheumatoid arthritis
ROS Therapeutics APS has developed a targeted methotrexate prodrug to mitigate the side effects experienced by many rheumatoid arthritis patients.
Danish start-up company ROS Therapeutics...
Womb inflammation may explain why some babies are prone to sepsis after birth
According to the American Journal of Pathology, infants are more likely to have sepsis after birth due to womb inflammation.
A new report highlights the...
